Schizophrenia Schizoaffective Clinical Trial
— pCRTOfficial title:
Testing the Feasibility and Acceptability of a New Personalised Form of Cognitive Remediation Therapy (pCRT) for People With Psychosis.
Cognitive deficits have been shown to have negative impact on social functioning and
functional goals such as ability to work and perform daily tasks in people with
schizophrenia. There is evidence that Cognitive Remediation Therapy, a form of psychological
therapy, is effective in improving cognition and functioning but there is still a limited
understanding of what influence people's different response to this therapy. A tailored
treatment is likely to be more effective because it will adapt to service users' unique
characteristics.
The investigators are planning a study exploring at the feasibility and acceptability of
novel form of Cognitive Remediation Therapy which is personalised (pCRT) to the person
individual characteristics. The personalised therapy will consist of task practice using
computerized Cognitive Remediation software (i.e. called CIRCuiTS). The knowledge gathered in
this work will contribute to develop the next generation of personalised treatment approaches
for people with schizophrenia.
Status | Not yet recruiting |
Enrollment | 15 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - a range of 18-65 years - English speaking or with a good knowledge of the language - a diagnosis of schizophrenia or schizoaffective disorder according to the DSM- V - at least one year contact with mental health services, - a deficit (of at least one standard deviation below the mean) in at least one cognitive domain out of these three cognitive domains: memory, executive function and information processing. Exclusion Criteria: - Planned medication change - Diagnosis of learning disability - Presence of cognitive deficits related to organic causes or head injury - Primary diagnosis of substance dependence |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
King's College London |
Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011 May;168(5):472-85. doi: 10.1176/appi.ajp.2010.10060855. Epub 2011 Mar 15. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of intervention (including acceptance rates, drop outs) | Feasibility estimates of delivering the intervention including acceptance rates, drop outs. | 3 months post baseline assessment | |
Secondary | Acceptability of intervention (Satisfaction) | Questionnaire of Satisfaction | 3 months post baseline assessment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05414058 -
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
|
Phase 2 | |
Recruiting |
NCT05660018 -
TMS Related Biomarker Assessments
|
N/A | |
Not yet recruiting |
NCT06275451 -
Qualitative Study of Emotional Regulation in Schizophrenia
|
||
Active, not recruiting |
NCT04325386 -
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
|
N/A | |
Completed |
NCT04567524 -
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
|
Phase 2 | |
Recruiting |
NCT05643196 -
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
|
Phase 2 |